Healthcare company Progressive Care (OTC PINK:RXMD) announced on Thursday that it achieved record breaking revenues of USD1.5m for March.
This revenue collection marks an improvement of 45% over March 2015 and nearly USD100,000 more than the last record breaking month in December 2015.
The company added that it broke its all-time sales records during March, filling approximately 18,600 prescriptions, up 36% over the same month last year and about 1,400 more prescriptions filled from the last highest month in September 2015.
In March 2016, the company began developing and marketing its own compound version of generic Viagra known as Sildenafil/Oxytocin. It is currently compounding the drug in a number of dosage forms including capsules and sublingual sprays.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development